Group One Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Group One Trading’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,600	Closed	-$88K	–	9154
2021 Q2	$88K	Buy	2,600 +1,600	+160%	+$40.8K	﹤0.01%	6092
2021 Q1	$23K	Buy	1,000 +700	+233%	+$21.2K	﹤0.01%	6713
2020 Q4	$9K	Buy	+300	New	+$7.55K	﹤0.01%	5854
2020 Q1	–	Sell	-100	Closed	-$5K	–	5996
2019 Q4	$5K	Buy	+100	New	+$2.89K	﹤0.01%	4763

Group One Trading's CNST Position: Q3 2020 in Review

Group One Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2020, closing a stake of 13 shares — an estimated $317 sold.

Group One Trading first reported a position in CNST in Q4 2019 and held it in 3 quarters. The position peaked at $10K in Q4 2019. 119 funds tracked by Wall St. Rank hold CNST as of Q3 2020.

Group One Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Group One Trading sold 13 Constellation Pharmaceuticals, Inc. shares in Q3 2020, an estimated $317.
Group One Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
Group One Trading's Constellation Pharmaceuticals, Inc. position peaked at $10K in Q4 2019.
119 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2020.

Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.